Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
VTR 
Ventas Inc (VTR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/29/2025: VTR (4-star) is a STRONG-BUY. BUY since 10 days. Profits (2.03%). Updated daily EoD!
Upturn Star Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Number of Analysts
20 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $75.72
1 Year Target Price $75.72
| 12 | Strong Buy |
| 5 | Buy |
| 3 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 39.29% | Avg. Invested days 52 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 07/29/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 30.17B USD | Price to earnings Ratio 202.52 | 1Y Target Price 75.72 |
Price to earnings Ratio 202.52 | 1Y Target Price 75.72 | ||
Volume (30-day avg) 20 | Beta 0.89 | 52 Weeks Range 53.09 - 70.82 | Updated Date 07/29/2025 |
52 Weeks Range 53.09 - 70.82 | Updated Date 07/29/2025 | ||
Dividends yield (FY) 2.81% | Basic EPS (TTM) 0.33 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-07-30 | When After Market | Estimate 0.13 | Actual - |
Profitability
Profit Margin 2.82% | Operating Margin (TTM) 14.15% |
Management Effectiveness
Return on Assets (TTM) 1.92% | Return on Equity (TTM) 1.38% |
Valuation
Trailing PE 202.52 | Forward PE 158.73 | Enterprise Value 42904636866 | Price to Sales(TTM) 5.97 |
Enterprise Value 42904636866 | Price to Sales(TTM) 5.97 | ||
Enterprise Value to Revenue 8.3 | Enterprise Value to EBITDA 20.98 | Shares Outstanding 451376000 | Shares Floating 448946984 |
Shares Outstanding 451376000 | Shares Floating 448946984 | ||
Percent Insiders 0.58 | Percent Institutions 100.75 |
Upturn AI SWOT
Ventas Inc
Company Overview
History and Background
Ventas, Inc. was founded in 1998. It is a leading Real Estate Investment Trust (REIT) that focuses on senior living communities, healthcare facilities, and research & innovation properties.
Core Business Areas
- Senior Living Communities: This segment involves owning and leasing senior living communities to operators under triple-net or operating leases. These properties include independent living, assisted living, and memory care facilities.
- Medical Office Buildings and Outpatient Medical Centers: This segment consists of owning medical office buildings and outpatient medical centers leased to physician groups, hospitals, and healthcare systems.
- Research & Innovation: This includes properties leased to universities, research institutions, and pharmaceutical companies for research and development activities.
- Hospitals: A smaller segment that includes acute-care and specialty hospitals.
Leadership and Structure
Debra Cafaro is the Chairman and CEO of Ventas. The company operates with a Board of Directors and a management team overseeing various departments such as finance, investments, and operations.
Top Products and Market Share
Key Offerings
- Senior Living Communities: Ventas owns and leases a large portfolio of senior living communities. Market share data fluctuates, but Ventas is a major player in the senior housing REIT sector. Competitors include Welltower (WELL) and Healthpeak Properties (PEAK).
- Medical Office Buildings (MOBs): Ventas is also a significant owner of medical office buildings, which are leased to healthcare providers. Market share data can vary by region and specific property type. Competitors include Healthcare Realty Trust (HR) and Physicians Realty Trust (DOC).
- Research & Innovation: Ventas offers state-of-the-art research and innovation facilities leased to top Universities and innovative organizations. Welltower (WELL) and Alexandria Real Estate Equities (ARE) are competitors.
Market Dynamics
Industry Overview
The healthcare REIT industry is influenced by demographic trends, interest rates, and regulatory changes. Aging populations drive demand for senior living and healthcare facilities.
Positioning
Ventas is positioned as a leading healthcare REIT with a diversified portfolio of high-quality assets. Their focus on research & innovation provides a unique competitive advantage.
Total Addressable Market (TAM)
The TAM for healthcare real estate is estimated to be in the hundreds of billions of dollars. Ventas is positioned to capture a significant share of this market through strategic acquisitions and developments.
Upturn SWOT Analysis
Strengths
- Diversified portfolio
- Strong management team
- Focus on high-growth sectors like research & innovation
- Long-term relationships with leading operators and healthcare systems
- Strong balance sheet
Weaknesses
- Exposure to interest rate fluctuations
- Dependence on operators' performance
- Potential for regulatory changes impacting healthcare
- High capital expenditure requirements
- Tenant concentration in specific markets
Opportunities
- Aging population driving demand for senior living
- Increasing healthcare spending
- Expansion into new markets
- Strategic acquisitions to grow portfolio
- Development of new healthcare facilities
Threats
- Economic downturn impacting occupancy rates
- Increased competition from other healthcare REITs
- Changes in government healthcare policies
- Rising interest rates increasing borrowing costs
- Labor shortages in healthcare industry
Competitors and Market Share
Key Competitors
- Welltower Inc (WELL)
- Healthpeak Properties Inc (PEAK)
- Alexandria Real Estate Equities Inc (ARE)
Competitive Landscape
Ventas competes with other healthcare REITs based on property quality, location, operator relationships, and access to capital. Ventas' focus on research & innovation provides a differentiator.
Major Acquisitions
New Senior Investment Group
- Year: 2022
- Acquisition Price (USD millions): 2300
- Strategic Rationale: Expanded Ventas' presence in the senior living sector.
Growth Trajectory and Initiatives
Historical Growth: Ventas has grown through acquisitions and development of new properties.
Future Projections: Analyst projections for Ventas' future growth would be included here.
Recent Initiatives: Recent strategic initiatives would be included here.
Summary
Ventas is a strong player in the healthcare REIT sector due to its diversified portfolio and strategic focus on research & innovation. The aging population presents significant opportunities, but interest rate risks and regulatory changes must be carefully managed. Ventas' ability to maintain strong operator relationships will be crucial for its future success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings (SEC)
- Investor Presentations
- Analyst Reports
- Industry Publications
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Ventas Inc
Exchange NYSE | Headquaters Chicago, IL, United States | ||
IPO Launch date 1998-05-04 | Chairman & CEO Ms. Debra A. Cafaro J.D. | ||
Sector Real Estate | Industry REIT - Healthcare Facilities | Full time employees 498 | Website https://www.ventasreit.com |
Full time employees 498 | Website https://www.ventasreit.com | ||
Ventas, Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its approximately 850 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OI platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas's seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.